| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Cancer in public figures, 2010-2020
|
Benjamin, D.J.
|
|
|
7 |
C |
p.
|
article
|
| 2 |
Cardiovascular toxicities in cancer patients treated with immune checkpoint inhibitors: multicenter study using natural language processing on Belgian hospital data
|
Delombaerde, D.
|
|
|
7 |
C |
p.
|
article
|
| 3 |
Characterisation of oncology EHR-derived real-world data in the UK, Germany, and Japan
|
Adamson, B.
|
|
|
7 |
C |
p.
|
article
|
| 4 |
Collaborating across sectors in service of open science, precision oncology, and patients: an overview of the AACR Project GENIE (Genomics Evidence Neoplasia Information Exchange) Biopharma Collaborative (BPC)
|
Acebedo, A.
|
|
|
7 |
C |
p.
|
article
|
| 5 |
Core variables for real-world clinicogenomic data collection in precision oncology
|
Dienstmann, R.
|
|
|
7 |
C |
p.
|
article
|
| 6 |
Data analytics for real-world data integration in TKI-treated NSCLC patients using electronic health records
|
Mazzeo, L.
|
|
|
7 |
C |
p.
|
article
|
| 7 |
Definitions, measurement, and reporting of progression-free survival in randomized clinical trials and observational studies of patients with advanced non-small-cell lung cancer treated with immunotherapy: a scoping review
|
Verschueren, M.V.
|
|
|
7 |
C |
p.
|
article
|
| 8 |
Editoiral Board
|
|
|
|
7 |
C |
p.
|
article
|
| 9 |
Evolving treatment patterns and outcomes among patients with metastatic urothelial carcinoma post-avelumab maintenance approval: insights from The US Oncology Network
|
Li, H.
|
|
|
7 |
C |
p.
|
article
|
| 10 |
Guidelines and variations in patterns of GnRH analogue use in castration-resistant prostate cancer across six countries
|
George, G.
|
|
|
7 |
C |
p.
|
article
|
| 11 |
Human epidermal growth factor receptor 2 (HER2) expression dynamics between diagnosis and recurrence in patients with breast cancer using artificial intelligence and electronic health records: the RosHER study
|
López-Miranda, E.
|
|
|
7 |
C |
p.
|
article
|
| 12 |
Impact of travel costs on disparities in precision oncology clinical trials
|
Uehara, Y.
|
|
|
7 |
C |
p.
|
article
|
| 13 |
Incidence, risk factors, and clinical implications of enfortumab vedotin-related cutaneous toxicity in urothelial carcinoma: a large-scale, real-world study in Japan
|
Kita, Y.
|
|
|
7 |
C |
p.
|
article
|
| 14 |
Neutrophil to lymphocyte ratio and tumour burden for treatment efficacy stratification in renal cell carcinoma patients receiving nivolumab plus ipilimumab
|
Oshima, M.
|
|
|
7 |
C |
p.
|
article
|
| 15 |
Off-label drug use in oncology: integrating molecular and genetic analysis in an academic center’s real-world approach
|
Cioli, E.
|
|
|
7 |
C |
p.
|
article
|
| 16 |
Perspectives, willingness, and current use of mobile health (mHealth) by patients with cancer for remote monitoring during cancer treatment: a Dutch national cross-sectional survey ☆
|
Stuijt, D.G.
|
|
|
7 |
C |
p.
|
article
|
| 17 |
Real-world management and outcome of patients with pancreatic adenocarcinoma. Results of the Spanish RETUD gastrointestinal registry
|
Macarulla, T.
|
|
|
7 |
C |
p.
|
article
|
| 18 |
Real-world safety and effectiveness data of trastuzumab deruxtecan and sacituzumab govitecan in breast cancer: a Hellenic Cooperative Oncology Group study
|
Fountzilas, E.
|
|
|
7 |
C |
p.
|
article
|
| 19 |
Reply to the Correspondence regarding “Sequencing the anti-EGFR-TKIs; route to the longest survival” by H.G. Güzel et al.
|
Uehara, Y.
|
|
|
7 |
C |
p.
|
article
|
| 20 |
Table of Contents
|
|
|
|
7 |
C |
p.
|
article
|
| 21 |
Utility of automated data transfer for cancer clinical trials and considerations for implementation
|
Pfeffer, M.
|
|
|
7 |
C |
p.
|
article
|
Journal description